Sean Tehrani
@seantehrani · Member since April 2026
Founder of PeptaHub. These reviews reflect my personal experience and biases — not medical advice.
Reviews (9)
Ran Semaglutide 0.5 mg weekly for 8 weeks, then switched to compounded Tirzepatide 5 mg weekly for the next 12. Weight-loss curve on Tirzepatide was about 1.5x my Semaglutide rate at comparable tolerance — the dual-agonist story tracks with what I lived through. Appetite-suppression was deeper on Tirzepatide (I went from "reliably full" to "actively uninterested in food" at the same meal size) but that cuts both ways: easier to miss protein targets, which matters if you care about lean mass. Nausea profile felt roughly similar at matched titration pace. Where Semaglutide still wins for me: cost predictability and the accessible compounded market is more mature. If I were choosing fresh today for pure weight-loss and budget wasn't the constraint, Tirzepatide. If I were maintenance-dosing, Semaglutide. Use case matters more than the "which is better" framing suggests.
Stacked BPC-157 and TB-500 across a single recovery cycle after they'd each been solo-tested in earlier cycles. BPC-157 at 250 mcg subQ twice daily was the "local" peptide for me — better for focal issues (specific tendon, specific GI concern). TB-500 at 2 mg weekly felt "systemic" — slower, broader, better for diffuse recovery where I couldn't point to one spot. The synergy angle held: the combined cycle resolved my shoulder issue faster than either solo had cleared comparable complaints. Tolerability was clean for both; BPC-157 has a slight edge on dose-frequency convenience (twice-daily) if you don't mind the needles versus TB-500 being weekly. Cost diff is real — TB-500 per-mg is significantly higher. If I had to pick one with a single complaint, I'd pick BPC for acute-local and TB-500 for chronic-diffuse.
Back-to-back 6-week trials: Ipamorelin first, Sermorelin second, same protocol slot, same sleep-tracking cadence. Ipamorelin at 200 mcg subQ pre-bed delivered a noticeable but modest signal — deeper sleep by wearable metrics, smoother next-morning energy. Sermorelin at 200 mcg in the same slot was flat for me; sleep-onset was marginally better but nothing I could defend as more than noise. Tolerability on both was clean. Price-per-week is where Sermorelin wins — about 60% cheaper at my source — but the efficacy gap in my n=1 swamps the cost savings. If I were choosing again for GH-release effect, I'd default Ipamorelin and only fall back to Sermorelin if budget made it impossible. Others clearly respond differently; this is about the relative ranking in my body, not a claim about either peptide's theoretical mechanism.
- Ipamorelin4/21/2026
Eight weeks on Ipamorelin at 200 mcg subQ pre-bed, then a second 200 mcg dose mid-morning in weeks 5-8. Sleep quality was the signal I could actually measure — faster sleep onset, fewer night wakes per my wearable's data. Recovery between sessions at the gym felt smoother, though isolating Ipamorelin from training periodization is hard. No appetite spike (which is the whole point of choosing Ipamorelin over GHRP-6 or MK-677). No tolerability issues at the 200 mcg dose; a brief head-rush for the first week on the mid-morning dose that faded. Pricey per-mg at retail, and you're going through a lot of it across 8 weeks. Efficacy rating reflects my modest expectations met; not a body-composition miracle, but a quiet baseline improvement.
- Sermorelin4/21/2026
Ran Sermorelin 200 mcg subQ pre-bed for 5 weeks as a cheaper alternative to Ipamorelin in a growth-hormone trial. For me, the HGH release was too subtle to justify the recurring cost. Sleep got marginally deeper in the first week (placebo? probably partly) but plateaued. No side effects, no injection issues — tolerability is fine. The math didn't land: per-week cost versus the signal I actually noticed. Others report better results and Sermorelin is clearly responder-dependent based on what I've read in the literature and other user reports. I'd tell someone on the fence: if budget is the constraint, try it for a 4-week window before committing; if you can afford Ipamorelin or CJC-1295, my limited A/B suggests those are more reliable. Not saying the peptide is bad — just that my response was flat.
- GHK-Cu4/21/2026
Used GHK-Cu topically (~1% solution from a compounded source) twice daily on forehead and around the eyes for 10 weeks. Pairing: layered on after vitamin-C serum, before moisturizer, morning and night. Skin-improvement effect exists but is slow and subtle — better hydration retention by week 4, slightly softer fine-line appearance by week 8, no dramatic 'reverse-aging' like the marketing promises. No irritation, no color change at application sites. If you're coming in without a basic skincare routine already dialed, this isn't a shortcut to 'good skin' — it's an additive on top of a working stack. Worth trying if you're responder-curious and budget allows. Not a standalone replacement for retinoids or sunscreen. Efficacy rating reflects 'real but modest'.
- TB-5004/21/2026
Layered TB-500 on top of BPC-157 for the back half of a recovery cycle after a shoulder impingement. Protocol: 2 mg weekly split into two 1 mg subQ doses, 6 weeks. The synergy story held up in my case — range-of-motion in overhead work came back faster than the prior BPC-only cycle had delivered. Slow and steady, not dramatic; you don't really feel TB-500 the way you feel a stimulant or a GLP-1. Zero injection-site complaints. The downside is timeline: if you want an answer in a week, this isn't your peptide. Mine was a 6-week decision before the diff felt real. Value rating: middle — more per-dose than BPC alone but meaningfully less than a PT visit cadence if you're otherwise routing through physical therapy. Not a universal endorsement; I'd repeat for the same type of issue.
- BPC-1574/21/2026
Ran BPC-157 250 mcg subQ twice daily for 4 weeks post-tendon strain. By week 2 I noticed reduced morning stiffness on the affected side. No injection-site reactions at the thinner-gauge needle. Full recovery wasn't instant — the sleeve I'd been using came off around week 5. Can't fully isolate BPC vs. rest, but the directionality felt right. One thing I'd tell someone considering it: the cost-per-dose stacks up fast if you're buying retail. Pre-research your supplier's pricing and minimum order quantities. Efficacy rating reflects my specific use case (recovery timeline), not a universal claim. If you're using it for something else (skin, GI), YMMV.
- Semaglutide4/21/2026
I'm PeptaHub's founder; writing this to dogfood our review system and make sure every surface has real content to evaluate. Ran Semaglutide 0.25 mg weekly for 8 weeks, titrating to 0.5 mg by week 5. Appetite suppression was the clearest signal — reliable 500-700 kcal drop per day without tracking hard, just from the "already full" feeling. Weight came off at roughly 0.4 kg/week once I hit the 0.5 mg dose, which matches what I'd read but felt different to actually live through. Nausea was real for the first 48 hours after each dose bump; a smaller evening meal on injection day handled most of it. The part I wasn't prepared for: cost-per-week adds up fast at retail pricing, and compounded sourcing decisions became their own research project. Efficacy rating reflects my specific weight-loss use case, not any broader metabolic claim. If you're looking at this for off-label reasons other than appetite/weight, my experience doesn't generalize.